Cardiovascular

Hydrochlorothiazide: Not Recommended For First-Line Therapy In Hypertension

June 18, 2009
Source: 19th European Meeting On Hypertension, Milan, June 12-16, 2009
Franz Messerli

Franz Messerli

New York cardiologist Franz Messerli explains to Peter Goodwin why he doesn’t prescribe the popular diuretic hydrochlorothiazide as initial therapy for hypertension any more, as he announced in a “Late-Breaker” session at the European Meeting on Hypertension in Milan.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Front Line Therapy in Non-Small Cell Lung Cancer

    • Nick Thatcher NICK THATCHER, Christie Hospital, Manchester There is a proven benefit in survival

  • American College of Cardiology, Orlando

    • The 2009 ACC scientific session began with a bang together with the i2 meeting on Saturday March 28th in Orlando,

  • Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension?

    • [caption id="attachment_844" align="alignnone" width="120" caption="Thomas Unger"][/caption]The illusive angiotensin AT2 receptor could become an important new target for therapy in the

    Post a comment